kimoks 400 mg tabletki powlekane
alkaloid - int d.o.o. - moxifloxacinum - tabletki powlekane - 400 mg
hydrocortisone momaja 100 mg proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań / do infuzji
panpharma - hydrocortisonum - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań / do infuzji - 100 mg
moxifloxacin genoptim 400 mg tabletki powlekane
synoptis pharma sp. z o.o. - moxifloxacini hydrochloridum - tabletki powlekane - 400 mg
xeljanz
pfizer europe ma eeig - Тофацитиниб - zapalenie stawów, reumatoidalne - leki immunosupresyjne - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 i 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
gastrovit travicomplex - płyn doustny
phytopharm klęka s.a. - salicis cortex + thymi herba + millefolii herba + quercus cortex + salviae herba + artemisiae abrotani herba - płyn doustny - -
salviasept - koncentrat do sporządzania roztworu do płukania gardła
zakłady farmaceutyczne polpharma s.a. - foeniculi fructus + mentholum + caryophylli aetheroleum + maioranae aetheroleum + cineolum + thymi aetheroleum + salviae aetheroleum + menthae piperitae aetheroleum - koncentrat do sporządzania roztworu do płukania gardła - -
apetiherb - syrop
wrocławskie zakłady zielarskie "herbapol" s.a. - extractum compositum fluidum (1:2) ex: - syrop - -
nervosan fix - zioła do zaparzania w saszetkach
zakłady farmaceutyczne polpharma s.a. - valerianae radix + melissae herba + chamomillae anthodium + menthae piperitae folium + millefolii herba - zioła do zaparzania w saszetkach - -
dr reckeweg r30 atomare beckeron - maść
pharmazeutische fabrik dr reckeweg & co gmbh - atropa belladonna d1 + pini sylvestris aetheroleum + rosmarini aetheroleum + arnica montana + solanum dulcamara d3 + strychnos nux - vomica ferm + toxicodendron quercifolium + calendula officinalis + hamamelis + hyperici perforati herba + achillea millefolium + echinacea + camphorum - maść - -
solifenacin sandoz 5 mg tabletki powlekane
sandoz gmbh - solifenacini succinas - tabletki powlekane - 5 mg